New York, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Xerostomia (Dry Mouth) Therapeutics Industry" - https://www.reportlinker.com/p06033322/?utm_source=GNW
6% over the period 2020-2027. Over-the-Counter, one of the segments analyzed in the report, is projected to record 3.7% CAGR and reach US$526 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Prescription segment is readjusted to a revised 3.4% CAGR for the next 7-year period.
The U.S. Market is Estimated at $187.5 Million, While China is Forecast to Grow at 5.8% CAGR
The Xerostomia (Dry Mouth) Therapeutics market in the U.S. is estimated at US$187.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$171.8 Million by the year 2027 trailing a CAGR of 5.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.1% and 2.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.
Select Competitors (Total 36 Featured) -
3M company
Advanz Pharma Corp. Limited
Bausch Health Companies Inc.
Fresenius SE & Co. KGaA
GlaxoSmithKline PLC
Hikma Pharmaceuticals PLC
Lupin Limited
Parnell Pharmaceuticals Inc.
Pharmascience Inc (Pendopharm)
Quest Products Inc.
Read the full report: https://www.reportlinker.com/p06033322/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Xerostomia (Dry Mouth) Therapeutics - Global Key Competitors
Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 3: World 15-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2021 & 2027
Table 4: World Recent Past, Current & Future Analysis for
Over-the-Counter by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 5: World Historic Review for Over-the-Counter by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 6: World 15-Year Perspective for Over-the-Counter by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 7: World Recent Past, Current & Future Analysis for
Prescription by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 8: World Historic Review for Prescription by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 9: World 15-Year Perspective for Prescription by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 10: World Recent Past, Current & Future Analysis for
Dentifrices by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 11: World Historic Review for Dentifrices by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 12: World 15-Year Perspective for Dentifrices by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 13: World Recent Past, Current & Future Analysis for
Salivary Stimulants by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 14: World Historic Review for Salivary Stimulants by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 15: World 15-Year Perspective for Salivary Stimulants by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 16: World Recent Past, Current & Future Analysis for
Salivary Substitutes by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 17: World Historic Review for Salivary Substitutes by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 18: World 15-Year Perspective for Salivary Substitutes by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 19: World Xerostomia (Dry Mouth) Therapeutics Market
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2027
III. MARKET ANALYSIS
UNITED STATES
Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United States
for 2022 (E)
Table 20: USA Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 21: USA Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 22: USA 15-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Type - Percentage Breakdown of Value Sales for
Over-the-Counter and Prescription for the Years 2012, 2021 &
2027
Table 23: USA Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 24: USA Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 25: USA 15-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Percentage Breakdown of Value
Sales for Dentifrices, Salivary Stimulants and Salivary
Substitutes for the Years 2012, 2021 & 2027
CANADA
Table 26: Canada Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 27: Canada Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 28: Canada 15-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Type - Percentage Breakdown of Value Sales for
Over-the-Counter and Prescription for the Years 2012, 2021 &
2027
Table 29: Canada Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 30: Canada Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 31: Canada 15-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Percentage Breakdown of Value
Sales for Dentifrices, Salivary Stimulants and Salivary
Substitutes for the Years 2012, 2021 & 2027
JAPAN
Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Table 32: Japan Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 33: Japan Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 34: Japan 15-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Type - Percentage Breakdown of Value Sales for
Over-the-Counter and Prescription for the Years 2012, 2021 &
2027
Table 35: Japan Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 36: Japan Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 37: Japan 15-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Percentage Breakdown of Value
Sales for Dentifrices, Salivary Stimulants and Salivary
Substitutes for the Years 2012, 2021 & 2027
CHINA
Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in China for 2022 (E)
Table 38: China Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 39: China Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 40: China 15-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Type - Percentage Breakdown of Value Sales for
Over-the-Counter and Prescription for the Years 2012, 2021 &
2027
Table 41: China Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 42: China Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 43: China 15-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Percentage Breakdown of Value
Sales for Dentifrices, Salivary Stimulants and Salivary
Substitutes for the Years 2012, 2021 & 2027
EUROPE
Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Table 44: Europe Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Geographic Region -
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 45: Europe Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 46: Europe 15-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia and
Rest of Europe Markets for Years 2012, 2021 & 2027
Table 47: Europe Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 48: Europe Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 49: Europe 15-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Type - Percentage Breakdown of Value Sales for
Over-the-Counter and Prescription for the Years 2012, 2021 &
2027
Table 50: Europe Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 51: Europe Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 52: Europe 15-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Percentage Breakdown of Value
Sales for Dentifrices, Salivary Stimulants and Salivary
Substitutes for the Years 2012, 2021 & 2027
FRANCE
Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in France for 2022 (E)
Table 53: France Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 54: France Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 55: France 15-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Type - Percentage Breakdown of Value Sales for
Over-the-Counter and Prescription for the Years 2012, 2021 &
2027
Table 56: France Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 57: France Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 58: France 15-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Percentage Breakdown of Value
Sales for Dentifrices, Salivary Stimulants and Salivary
Substitutes for the Years 2012, 2021 & 2027
GERMANY
Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Table 59: Germany Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 60: Germany Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 61: Germany 15-Year Perspective for Xerostomia (Dry
Mouth) Therapeutics by Type - Percentage Breakdown of Value
Sales for Over-the-Counter and Prescription for the Years 2012,
2021 & 2027
Table 62: Germany Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 63: Germany Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 64: Germany 15-Year Perspective for Xerostomia (Dry
Mouth) Therapeutics by Product Segment - Percentage Breakdown
of Value Sales for Dentifrices, Salivary Stimulants and
Salivary Substitutes for the Years 2012, 2021 & 2027
ITALY
Table 65: Italy Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 66: Italy Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 67: Italy 15-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Type - Percentage Breakdown of Value Sales for
Over-the-Counter and Prescription for the Years 2012, 2021 &
2027
Table 68: Italy Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 69: Italy Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 70: Italy 15-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Percentage Breakdown of Value
Sales for Dentifrices, Salivary Stimulants and Salivary
Substitutes for the Years 2012, 2021 & 2027
UNITED KINGDOM
Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United Kingdom
for 2022 (E)
Table 71: UK Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 72: UK Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 73: UK 15-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Type - Percentage Breakdown of Value Sales for
Over-the-Counter and Prescription for the Years 2012, 2021 &
2027
Table 74: UK Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 75: UK Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 76: UK 15-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Percentage Breakdown of Value
Sales for Dentifrices, Salivary Stimulants and Salivary
Substitutes for the Years 2012, 2021 & 2027
SPAIN
Table 77: Spain Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 78: Spain Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 79: Spain 15-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Type - Percentage Breakdown of Value Sales for
Over-the-Counter and Prescription for the Years 2012, 2021 &
2027
Table 80: Spain Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 81: Spain Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 82: Spain 15-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Percentage Breakdown of Value
Sales for Dentifrices, Salivary Stimulants and Salivary
Substitutes for the Years 2012, 2021 & 2027
RUSSIA
Table 83: Russia Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 84: Russia Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 85: Russia 15-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Type - Percentage Breakdown of Value Sales for
Over-the-Counter and Prescription for the Years 2012, 2021 &
2027
Table 86: Russia Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 87: Russia Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 88: Russia 15-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Percentage Breakdown of Value
Sales for Dentifrices, Salivary Stimulants and Salivary
Substitutes for the Years 2012, 2021 & 2027
REST OF EUROPE
Table 89: Rest of Europe Recent Past, Current & Future Analysis
for Xerostomia (Dry Mouth) Therapeutics by Type -
Over-the-Counter and Prescription - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 90: Rest of Europe Historic Review for Xerostomia (Dry
Mouth) Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 91: Rest of Europe 15-Year Perspective for Xerostomia
(Dry Mouth) Therapeutics by Type - Percentage Breakdown of
Value Sales for Over-the-Counter and Prescription for the Years
2012, 2021 & 2027
Table 92: Rest of Europe Recent Past, Current & Future Analysis
for Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 93: Rest of Europe Historic Review for Xerostomia (Dry
Mouth) Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 94: Rest of Europe 15-Year Perspective for Xerostomia
(Dry Mouth) Therapeutics by Product Segment - Percentage
Breakdown of Value Sales for Dentifrices, Salivary Stimulants
and Salivary Substitutes for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Asia-Pacific for
2022 (E)
Table 95: Asia-Pacific Recent Past, Current & Future Analysis
for Xerostomia (Dry Mouth) Therapeutics by Geographic Region -
Australia, India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2020 through 2027 and % CAGR
Table 96: Asia-Pacific Historic Review for Xerostomia (Dry
Mouth) Therapeutics by Geographic Region - Australia, India,
South Korea and Rest of Asia-Pacific Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 97: Asia-Pacific 15-Year Perspective for Xerostomia (Dry
Mouth) Therapeutics by Geographic Region - Percentage Breakdown
of Value Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2021 & 2027
Table 98: Asia-Pacific Recent Past, Current & Future Analysis
for Xerostomia (Dry Mouth) Therapeutics by Type -
Over-the-Counter and Prescription - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 99: Asia-Pacific Historic Review for Xerostomia (Dry
Mouth) Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 100: Asia-Pacific 15-Year Perspective for Xerostomia (Dry
Mouth) Therapeutics by Type - Percentage Breakdown of Value
Sales for Over-the-Counter and Prescription for the Years 2012,
2021 & 2027
Table 101: Asia-Pacific Recent Past, Current & Future Analysis
for Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 102: Asia-Pacific Historic Review for Xerostomia (Dry
Mouth) Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 103: Asia-Pacific 15-Year Perspective for Xerostomia (Dry
Mouth) Therapeutics by Product Segment - Percentage Breakdown
of Value Sales for Dentifrices, Salivary Stimulants and
Salivary Substitutes for the Years 2012, 2021 & 2027
AUSTRALIA
Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Australia for 2022
(E)
Table 104: Australia Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 105: Australia Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 106: Australia 15-Year Perspective for Xerostomia (Dry
Mouth) Therapeutics by Type - Percentage Breakdown of Value
Sales for Over-the-Counter and Prescription for the Years 2012,
2021 & 2027
Table 107: Australia Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 108: Australia Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 109: Australia 15-Year Perspective for Xerostomia (Dry
Mouth) Therapeutics by Product Segment - Percentage Breakdown
of Value Sales for Dentifrices, Salivary Stimulants and
Salivary Substitutes for the Years 2012, 2021 & 2027
INDIA
Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in India for 2022 (E)
Table 110: India Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter
and Prescription - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 111: India Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 112: India 15-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Type - Percentage Breakdown of Value Sales for
Over-the-Counter and Prescription for the Years 2012, 2021 &
2027
Table 113: India Recent Past, Current & Future Analysis for
Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 114: India Historic Review for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 115: India 15-Year Perspective for Xerostomia (Dry Mouth)
Therapeutics by Product Segment - Percentage Breakdown of Value
Sales for Dentifrices, Salivary Stimulants and Salivary
Substitutes for the Years 2012, 2021 & 2027
SOUTH KOREA
Table 116: South Korea Recent Past, Current & Future Analysis
for Xerostomia (Dry Mouth) Therapeutics by Type -
Over-the-Counter and Prescription - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 117: South Korea Historic Review for Xerostomia (Dry
Mouth) Therapeutics by Type - Over-the-Counter and Prescription
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 118: South Korea 15-Year Perspective for Xerostomia (Dry
Mouth) Therapeutics by Type - Percentage Breakdown of Value
Sales for Over-the-Counter and Prescription for the Years 2012,
2021 & 2027
Table 119: South Korea Recent Past, Current & Future Analysis
for Xerostomia (Dry Mouth) Therapeutics by Product Segment -
Dentifrices, Salivary Stimulants and Salivary Substitutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 120: South Korea Historic Review for Xerostomia (Dry
Mouth) Therapeutics by Product Segment - Dentifrices, Salivary
Stimulants and Salivary Substitutes Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 121: South Korea 15-Year Perspective for Xerostomia (Dry
Mouth) Therapeutics by Product Segment - Percentage Breakdown
of Value Sales for Dentifrices, Salivary Stimulants and
Salivary Substitutes for the Years 2012, 2021 & 2027
REST OF ASIA-PACIFIC
Table 122: Rest of Asia-Pacific Recent Past, Current & Future
Analysis for Xerostomia (Dry Mouth) Therapeutics by Type -
Over-the-Counter and Prescription - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 123: Rest of Asia-Pacific Historic Review for Xerostomia
(Dry Mouth) Therapeutics by Type - Over-the-Counter and
Prescription Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 124: Rest of Asia-Pacific 15-Year Perspective for
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06033322/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
